Biktarvy 50-200-25 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FA0LA
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $72,078
Award facts
- Contract value 100% obligated
- $72,077.99 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. This competitively awarded, non-set-aside contract carries a ceiling value of approximately $72,078 and a firm fixed price structure, with an ultimate completion date of December 5, 2025. The place of performance is listed as AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 prime contract vehicle running through December 2026 that enables the company to supply comprehensive pharmaceutical products and medical supplies globally to support military healthcare programs.
AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor within the federal supply chain, providing brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive portfolio of federal contract awards demonstrates consistent capability to fulfill competitive procurement requirements for military and veteran healthcare needs. The current delivery order for Biktarvy, an antiretroviral medication, reflects the company's role in supplying specialized pharmaceutical products essential to military healthcare operations.
Quick answers
Who was awarded contract SPE2DR26FA0LA?
SPE2DR26FA0LA was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 4, 2025.
How much is contract SPE2DR26FA0LA worth?
The government has obligated $72,078 on SPE2DR26FA0LA.
Is contract SPE2DR26FA0LA an order under another contract?
Yes. SPE2DR26FA0LA is a delivery order under SPE2DR25D2100, an indefinite delivery contract.
Was contract SPE2DR26FA0LA competed?
The extent of competition for SPE2DR26FA0LA was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award